Hosted on MSN11mon
MHRA approves TMC Pharma’s fosdenopterin for MoCD type A
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved TMC Pharma's fosdenopterin (Nulibry) for the treatment of molybdenum cofactor deficiency (MoCD) type A. This rare ...
University of Wyoming3y
Enrichment of Azotobacter, a N2 Fixing Bacterium
Mannitol is included in the medium as an energy source and an ion of molybdenum that is essential for nitrogen fixation. This metallic ion appears to serve as an essential ion cofactor for the enzyme ...